Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2+P253R mice

BMC Developmental Biology

Volumn 10, Issue , 2010, Pages

  Wang, Yingli ^a   Sun, Miao ^b,c   Uhlhorn, Victoria L ^a   Zhou, Xueyan ^a   Peter, Inga ^a   Martinez Abadias, Neus ^d   Hill, Cheryl A ^d   Percival, Christopher J ^d   Richtsmeier, Joan T ^b,d   Huso, David L ^b   Jabs, Ethylin Wang ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUS; MUS MUSCULUS;

FIBROBLAST GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE P38;

ACROCEPHALOSYNDACTYLY; AMINO ACID SUBSTITUTION; ANIMAL; ARTICLE; C57BL MOUSE; CONGENITAL MALFORMATION; DISEASE MODEL; GENETICS; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; SKULL;

ACROCEPHALOSYNDACTYLIA; AMINO ACID SUBSTITUTION; ANIMALS; DISEASE MODELS, ANIMAL; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SKULL;

EID: 77649302376     PISSN: None     EISSN: 1471213X     Source Type: Journal    
DOI: 10.1186/1471-213X-10-22     Document Type: Article

References (66)

1. Diverse forms of a receptor for acidic and basic fibroblast growth factors. DE Johnson PL Lee J Lu LT Williams, Mol Cell Biol 1990 10 4728 4736 2167437
2. Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. SK Olsen OA Ibrahimi A Raucci F Zhang AV Eliseenkova A Yayon C Basilico RJ Linhardt J Schlessinger M Mohammadi, Proc Natl Acad Sci USA 2004 101 935 940 10.1073/pnas.0307287101 14732692
3. Cellular signaling by fibroblast growth factor receptors. VP Eswarakumar I Lax J Schlessinger, Cytokine Growth Factor Rev 2005 16 139 149 10.1016/j.cytogfr.2005.01.001 15863030
4. Fibroblast growth factors. DM Ornitz N Itoh, Genome Biol 2001 2 eviews3005 10.1186/gb-2001-2-3-reviews3005 11276432
5. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. T Miki DP Bottaro TP Fleming CL Smith WH Burgess AM Chan SA Aaronson, Proc Natl Acad Sci USA 1992 89 246 250 10.1073/pnas.89.1.246 1309608
6. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). A Orr-Urtreger MT Bedford T Burakova E Arman Y Zimmer A Yayon D Givol P Lonai, Dev Biol 1993 158 475 486 10.1006/dbio.1993. 1205 8393815
7. Receptor specificity of the fibroblast growth factor family. DM Ornitz J Xu JS Colvin DG McEwen CA MacArthur F Coulier G Gao M Goldfarb, J Biol Chem 1996 271 15292 15297 10.1074/jbc.271.25.15292 8663044
8. Cell signaling by ceceptor tyrosine kinases. J Schlessinger, Cell 2000 103 211 225 10.1016/S0092-8674(00)00114-8 11057895
9. Mechanisms underlying differential responses to FGF signaling. L Dailey D Ambrosetti A Mansukhani C Basilico, Cytokine Growth Factor Rev 2005 16 233 247 10.1016/j.cytogfr.2005.01.007 15863038
10. Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation. Y Hu E Chan SX Wang B Li, Endocrinology 2003 144 2068 2074 10.1210/en.2002-220863 12697715
11. p38 mitogen-activated protein kinase regulates osteoblast differentiation through osterix. X Wang CH Goh B Li, Endocrinology 2007 148 1629 1637 10.1210/en.2006-1000 17185377
12. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. G Xiao D Jiang R Gopalakrishnan RT Franceschi, J Biol Chem 2002 277 36181 36187 10.1074/jbc.M206057200 12110689
13. Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways. A Raucci P Bellosta R Grassi C Basilico A Mansukhani, J Cell Physio 2008 215 442 451 10.1002/jcp.21323
14. Fibroblast growth factor signaling controlling osteoblast differentiation. PJ Marie, Gene 2003 316 23 32 10.1016/S0378-1119(03)00748-0 14563548
15. Fibroblast growth factor-2(FGF-2) increases N-cadherin expression through protein kinase C and Src-kinase pathways in human calvaria osteoblasts. F Debiais J Lemonnier E Hay P Delannoy J Caverzasio PJ Marie, J Cell Biochem 2001 81 68 81 10.1002/1097-4644(20010401)81:1<68::AID-JCB1024>3.0.CO;2-S 11180398
16. Tissue origins and interactions in the mammalian skull vault. X Jiang S Iseki RE Maxson HM Sucov GM Morriss-Kay, Dev Biol 2002 241 106 116 10.1006/dbio.2001.0487 11784098
17. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. S Iseki AO Wilkie JK Heath T Ishimaru K Eto GM Morriss-Kay, Development 1997 124 3375 3384 9310332
18. Integration of FGF and TWIST in calvarial bone and suture development. DP Rice T Aberg Y Chan Z Tang PJ Kettunen L Pakarinen RE Maxson I Thesleff, Development 2000 127 1845 1855 10751173
19. Bone development. BR Olsen AM Reginato W Wang, Annu Rev Cell Dev Biol 2000 16 191 220 10.1146/annurev.cellbio.16.1.191 11031235
20. Development and tissue origins of the mammalian cranial base. B McBratney-Owen S Iseki SD Bamforth BR Olsen GM Morriss-Kay, Dev Biol 2008 322 121 132 10.1016/j.ydbio.2008.07.016 18680740
21. Review of fate-mapping studies of osteogenic cranial neural crest in vertebrates. JB Gross J Hanken, Dev Biol 2008 15:317 2 389 400 10.1016/j.ydbio.2008.02.046
22. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. S Iseki AO Wilkie GM Morriss-Kay, Development 1999 126 5611 5620 10572038
23. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. N Ohbayashi M Shibayama Y Kurotaki M Imanishi T Fujimori N Itoh S Takada, Genes Dev 2002 16 870 879 10.1101/gad.965702 11937494
24. Suture formation, premature sutural fusion, and suture default zones in Apert syndrome. MM Cohen Jr S Kreiborg, Am J Med Genet 1996 62 339 344 10.1002/(SICI)1096-8628(19960424)62:4<339::AID-AJMG3>3.0.CO;2-M 8723061
25. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. AO Wilkie SF Slaney M Oldridge MD Poole GJ Ashworth AD Hockley RD Hayward DJ David LJ Pulleyn P Rutland, Nat Genet 1995 9 165 172 10.1038/ng0295-165 7719344
26. Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. WJ Park C Theda NE Maestri GA Meyers JS Fryburg C Dufresne MM Cohen Jr EW Jabs, Am J Hum Genet 1995 57 321 328 7668257
27. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. J Anderson HD Burns P Enriquez-Harris AO Wilkie JK Heath, Hum Mol Genet 1998 7 1475 1483 10.1093/hmg/7.9.1475 9700203
28. Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. K Yu AB Herr G Waksman DM Ornitz, Proc Natl Acad Sci USA 2000 97 14536 14541 10.1073/pnas.97.26.14536 11121055
29. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. OA Ibrahimi AV Eliseenkova AN Plotnikov K Yu DM Ornitz M Mohammadi, Proc Natl Acad Sci USA 2001 98 7182 7187 10.1073/pnas.121183798 11390973
30. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. A Lomri J Lemonnier M Hott Nde Parseval E Lajeunie A Munnich D Renier PJ Marie, J Clin Invest 1998 101 1310 1317 9502772
31. Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. A Fragale M Tartaglia S Bernardini AM Di Stasi C Di Rocco F Velardi A Teti PA Battaglia S Migliaccio, Am J Pathol 1999 154 1465 1477 10329600
32. Increased osteoblast apoptosis in Apert craniosynostosis: Role of protein kinase C and interleukin-1. J Lemonnier E Ha P Delannoy O Fromigué A Lomri D Modrowski PJ Marie, Am J Pathol 2001 158 1833 1842 11337381
33. A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 Fgfr2 results in craniosynostosis. L Chen D Li C Li A Engel CX Deng, Bone 2003 33 169 178 10.1016/S8756-3282(03)00222-9 14499350
34. Abnormalities in cartilage and bone development in the Apert syndrome FGFR2+/S252W mouse. Y Wang R Xiao F Yang BO Karim AJ Iacovelli J Cai CP Lerner JT Richtsmeier JM Leszl CA Hill K Yu DM Ornitz J Elisseeff DL Huso EW Jabs, Development 2005 132 3537 3548 10.1242/dev.01914 15975938
35. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis. L Yin X Du C Li X Xu Z Chen N Su L Zhao H Qi F Li J Xue J Yang M Jin C Deng L Chen, Bone 2008 42 631 43 10.1016/j.bone.2007.11. 019 18242159
36. Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology. G Holmes G Rothschild UB Roy CX Deng A Mansukhani C Basilico, Dev Biol 2009 328 273 284 10.1016/j.ydbio.2009.01.026 19389359
37. RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. V Shukla X Coumoul RH Wang HS Kim CX Deng, Nat Genet 2007 39 1145 1150 10.1038/ng2096 17694057
38. A coordinate-free approach to the analysis of growth patterns: models and theoretical considerations. JT Richtsmeier S Lele, Biol Rev Camb Philos Soc 1993 68 381 411 10.1111/j.1469-185X.1993.tb00737.x 8347767
39. De l'acrocephalosyndactylie. ME Apert, Bulletin de la Société des médecins des hpitaux de Paris 1906 23 1310 1313
40. MM Cohen, Craniosynostosis: Diagnosis, Evaluation, and. Management New York Raven Press 1986
41. The oral manifestations of Apert syndrome. S Kreiborg MM Cohen Jr, J Craniofac Genet Dev Biol 1992 3 41 48
42. Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome. SF Slaney M Oldridge JA Hurst GM Moriss-Kay CM Hall MD Poole AO Wilkie, Am J Hum Genet 1996 58 923 932 8651276
43. Genotype-phenotype analysis in Apert syndrome suggests opposite effects of the two recurrent mutations on syndactyly and outcome of craniofacial surgery. S von Gernet A Golla Y Ehrenfels S Schuffenhauer JD Fairley, Clin Genet 2000 57 137 139 10.1034/j.1399-0004.2000.570208.x 10735635
44. Clinical and radiographic presentation and preparation of the prototyping model for pre-surgical planning in Apert's syndrome. EK Sannomiya SAB Reis J Asaumi AS Barbara K Kishi, Dentomaxillofac Radiol 2006 35 119 124 10.1259/dmfr/77056158 16549440
45. P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation. T Baroni P Carinci C Lilli C Bellucci MC Aisa L Scapoli S Volinia F Carinci F Pezzetti M Calvitti A Farina C Conte M Bodo, J Cell Physiol 2005 202 524 535 10.1002/jcp.20148 15389579
46. The study of abnormal bone development in the Apert syndrome Fgfr2+/S252W mouse using a 3D hydrogel culture model. F Yang Y Wang Z Zhang B Hsu EW Jabs JH Elisseeff, Bone 2008 43 55 63 10.1016/j.bone.2008.02.008 18407821
47. Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies. GM Morriss-Kay AO Wilkie, J Anat 2005 207 637 653 16313397
48. Fibroblast growth factor signaling in cranial suture development and pathogenesis. MK Hajihosseini, Front Oral Biol 2008 12 160 177 Review 18391500
49. Craniosynostosis in Twist heterozygous mice: a model for Saethre-Chotzen syndrome. EA Carver KF Oram T Gridley, Anat Rec 2002 268 90 92 10.1002/ar.10124 12221714
50. A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. YX Zhou X Xu L Chen C Li SG Brodie CX Deng, Hum Mol Genet 2000 9 2001 2008 10.1093/hmg/9.13.2001 10942429
51. A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes. MK Hajihosseini S Wilson L De Moerlooze C Dickson, Proc Natl Acad Sci 2001 98 3855 3860 10.1073/pnas.071586898 11274405
52. A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. VP Eswarakumar E Monsonego-Ornan M Pines I Antonopoulou GM Morriss-Kay P Lonai, Proc Natl Acad Sci USA 2004 101 12555 12560 10.1073/pnas.0405031101 15316116
53. The role of Axin2 in calvarial morphogenesis and craniosynostosis. HM Yu B Jerchow TJ Sheu B Liu F Costantini JE Puzas W Birchmeier W Hsu, Development 2005 132 1995 2005 10.1242/dev.01786 15790973
54. Skeletal analysis of the Fgfr3(P244R) mouse, a genetic model for the Muenke craniosynostosis syndrome. SR Twigg C Healy C Babbs JA Sharpe WG Wood PT Sharpe GM Morriss-Kay AO Wilkie, Dev Dyn 2009 238 331 342 10.1002/dvdy.21790 19086028
55. Cell mixing at a neural crest-mesoderm boundary and deficient ephrin-Eph signaling in the pathogenesis of craniosynostosis. AE Merrill EG Bochukova SM Brugger M Ishii DT Pilz SA Wall KM Lyons AO Wilkie RE Maxson Jr, Hum Mol Genet 2006 15 1319 1328 10.1093/hmg/ddl052 16540516
56. EphA4 as an effector of Twist1 in the guidance of osteogenic precursor cells during calvarial bone growth and in craniosynostosis. MC Ting NL Wu PG Roybal J Sun L Liu Y Yen RE Maxson Jr, Development 2009 136 855 864 10.1242/dev.028605 19201948
57. Exression patterns of Twist and Fgfr1, -2 and -3 in the developing mouse coronal suture suggest a key role for twist in suture initiation and biogenesis. D Johnson S Iseki AO Wilkie GM Morriss-Kay, Mech Dev 2000 91 341 345 10.1016/S0925-4773(99)00278-6 10704861
58. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. EW Jabs X Li AF Scott G Meyers W Chen M Eccles JI Mao LR Charnas CE Jackson M Jaye, Nat Genet 1994 8 275 279 10.1038/ng1194-275 7874170
59. Roles of FGFR2 and twist in human craniosynostosis: insights from genetic mutations in cranial osteoblasts. PJ Marie K Kaabeche H Guenou, Front Oral Biol 2008 12 144 159 18391499
60. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. V el Ghouzzi M Le Merrer F Perrin-Schmitt E Lajeunie P Benit D Renier P Bourgeois AL Bolcato-Bellemin A Munnich J Bonaventure, Nat Genet 1994 15 42 46 10.1038/ng0197-42
61. Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure. J Connerney V Andreeva Y Leshem MA Mercado K Dowell X Yang V Lindner RE Friesel DB Spicer, Dev Biol 2008 318 323 334 10.1016/j.ydbio.2008.03.037 18471809
62. Staining embryos for cartilage and bone. B Hogan R Beddington F Constantini E Lacy, Manipulating the Mouse Embryo: A Laboratory Manual Plainview, New York: Cold Spring Harbor Laboratory Press 2 1994 379
63. Measuring precision of three-dimensional landmark data. BD Corner S Lele JT Richtsmeier, Quant Anthropol 1992 3 347 359
64. Precision, repeatability, and validation of the localization of cranial landmarks using computed tomography scans. JT Richtsmeier C Paik P Elfert TI Cole H Dahlman, Cleft Palate Craniofac J 1995 32 217 227 10.1597/1545-1569(1995) 032<0217:PRAVOT>2.3.CO;2 7605789
65. S Lele JT Richtsmeier, An invariant approach to the statistical analysis of shapes London: Chapman and Hall/CRC Press 2001
66. DG Wilkinson, In situ hybridization: a practical approach London, UK: Oxford University Press 1992